UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by PSI Advisors LLC

PSI Advisors LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 68.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 557 shares of the healthcare conglomerate’s stock after buying an additional 226 shares during the quarter. PSI Advisors LLC’s holdings in UnitedHealth Group were worth $282,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. First Financial Corp IN lifted its position in shares of UnitedHealth Group by 3.5% during the fourth quarter. First Financial Corp IN now owns 2,001 shares of the healthcare conglomerate’s stock worth $1,012,000 after purchasing an additional 68 shares during the last quarter. PFW Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $1,527,000. Marion Wealth Management increased its holdings in shares of UnitedHealth Group by 2.5% in the 4th quarter. Marion Wealth Management now owns 5,261 shares of the healthcare conglomerate’s stock valued at $2,661,000 after acquiring an additional 129 shares during the last quarter. Courier Capital LLC lifted its stake in UnitedHealth Group by 0.8% during the fourth quarter. Courier Capital LLC now owns 4,193 shares of the healthcare conglomerate’s stock worth $2,121,000 after purchasing an additional 32 shares during the last quarter. Finally, Sunflower Bank N.A. increased its stake in UnitedHealth Group by 9.8% during the fourth quarter. Sunflower Bank N.A. now owns 1,743 shares of the healthcare conglomerate’s stock valued at $882,000 after purchasing an additional 156 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 4.0 %

NYSE:UNH opened at $541.28 on Tuesday. The stock has a market cap of $498.13 billion, a PE ratio of 35.26, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock’s 50-day moving average is $554.92 and its two-hundred day moving average is $562.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.56 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the stock. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. KeyCorp assumed coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. TD Cowen lifted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, Cantor Fitzgerald lifted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a report on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.